These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 574040)

  • 21. The interaction between prostaglandin E1 and delta 9-tetrahydrocannabinol on intestinal motility and on the abdominal constriction response in the mouse.
    Jackson DM; Malor R; Chesher GB; Starmer GA; Welburn PJ; Bailey R
    Psychopharmacologia; 1976 May; 47(2):187-93. PubMed ID: 1273216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoids and pain responses: a possible role for prostaglandins.
    Burstein SH; Hull K; Hunter SA; Latham V
    FASEB J; 1988 Nov; 2(14):3022-6. PubMed ID: 2846397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide.
    Pertwee RG; Greentree SG
    Neuropharmacology; 1988 May; 27(5):485-91. PubMed ID: 2839791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
    Taffe MA; Creehan KM; Vandewater SA
    Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 9 alpha, 10 alpha-epoxyhexahydrocannabinol formation from delta 9-tetrahydrocannabinol by liver microsomes of phenobarbital-treated mice and its pharmacological activities in mice.
    Narimatsu S; Yamamoto I; Watanabe K; Yoshimura H
    J Pharmacobiodyn; 1983 Aug; 6(8):558-64. PubMed ID: 6315913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabidiol-Δ
    Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
    Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
    Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandins and cannabis--IX. Stimulation of prostaglandin E2 synthesis in human lung fibroblasts by delta 1-tetrahydrocannabinol.
    Burstein S; Hunter SA; Sedor C; Shulman S
    Biochem Pharmacol; 1982 Jul; 31(14):2361-5. PubMed ID: 6289843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
    Murphy LL; Steger RW; Smith MS; Bartke A
    Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of delta 1-tetrahydrocannabinol on cyclic AMP in cultured human diploid fibroblasts.
    Kelly LA; Butcher RW
    J Cyclic Nucleotide Res; 1979; 5(4):303-13. PubMed ID: 91629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypothermic response of mice to delta-9-tetrahydrocannabinol is enhanced by chlorpromazine, thioxanthenes, alpha-adrenoceptor antagonists and pentolinium but not by SCH 23390 or sulpiride.
    Pertwee RG; Hedley D; McQueen AS; Gentleman SM
    Neuropharmacology; 1988 Feb; 27(2):149-55. PubMed ID: 2895430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadal hormone modulation of ∆
    Craft RM; Haas AE; Wiley JL; Yu Z; Clowers BH
    Pharmacol Biochem Behav; 2017 Jan; 152():36-43. PubMed ID: 27670094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
    Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
    Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response.
    Baczynsky WO; Zimmerman AM
    Pharmacology; 1983; 26(1):1-11. PubMed ID: 6298841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.